+91-33-4600-9199  (India), +1-414-240-5010 (U.S.)

Global Hypertension Drug Market (By Type- Beta Blockers, Diuretics, Renin Inhibitors, Alpha-Beta Blockers, Alpha Blockers, Vasodilators, Calcium Channel Blockers and Others) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 – 2025

Published Date : December, 2017 | Report Id : HC115 | Format : Word PDF, PPT PDF, Excel | Slides : 150
Report Type : Syndicate Report

Hypertension can also be referred as high blood pressure or arterial hypertension. Hypertension is a long-term medical condition, where the blood pressure reachesfrom high level to alarming levels. Hypertension can cause damage to organs and cause various illnesses which include heart failure, renal failure, heart attack and aneurysm. Mainly there are two kinds of hypertension, one is the primary hypertension and the other one is secondary hypertension. Smoking, exercising, excess body weight and several other reasons are the prime causes of hypertension. Hypertension Drug are used to minimize the level of high blood pressure. Healthy diet, physical exercise, decreased salt intake, and other lifestyle changes are some other ways to treat hypertension. Hypertension medicines are often treated as life-saving medicines for patients having high blood pressure. Intake of hypertension medicines is a long-term process and shouldn’t be stopped even when the blood pressure comes down. Increasing community of older people and rising number of men and women suffering from hypertension, contribute towards the growth of the hypertension Drug market. Moreover, growing awareness in people to treat high blood pressure or hypertension also leads to augment the market growth of hypertension Drug during the projection period of 2017-2025.


Increasing number of patients suffering from high blood pressure, especially geriatric population, propels the growth of hypertension medicines market. Along with the increase in age, the risk of pulmonary hypertension also develops which augments the growth of hypertension medicines among older population. Further down, rising awareness among people to treat hypertension also creates a high demand and huge market opportunity for anti-hypertension drugs in the coming years. In addition to this, Hypertension education program launched in some countries around the world by voluntary health agencies, professionals and state health departments, to diminish death and other causes related to hypertension is also further expected to make the market more demanding over the next eight years.


The hypertension Drug market in report is segmented by types which includes beta blockers, diuretics, renin inhibitors, alpha-beta blockers, alpha blockers, vasodilators, calcium channel blockers and others. The global hypertension Drug market has been moreover segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.


Product innovation and high investment made by leading key vendors, thereby enhances the market growth of hypertension medicines. Moreover, leading key vendors R&D activities is also expected to forecast high growth opportunity for hypertension Drug market. However, some side effects of high blood pressure medicines may hinder the growth of the market. The side effects of such medicines include dizziness, headache, fast heart beat, sleeping problems, upset stomach and swelling of hands, ankles, feet or legs. Some of these problems related to hypertension Drug are expected to affect the growth of the market over the forecasted years.


Some of the major players in the global hypertension Drug marketincludeGlaxoSmithKline PLC, Lupin Limited, Pfizer Inc., Johnson & Johnson Ltd., Sanofi S.A. and few others.


Global Hypertension Drug Market: By Type

  • Beta Blockers
  • Diuretics
  • Renin Inhibitors
  • Alpha-Beta Blockers
  • Alpha Blockers
  • Vasodilators
  • Calcium Channel Blockers
  • Others

Global Hypertension Drug Market: By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Rest of Latin America
Note: This table of contents is a content of a published report. As per client requirement, cross-sectional analysis across all industries or specific geography or ‘country-based’ analysis can be provided as a part of paid customization. Please place your queries on sales@sheeranalyticsandinsights.com or query@sheeranalyticsandinsights.com

Buy Chapters or Sections

Customization options available to meet your custom research requirements :

  • Request a part of this report
  • Get geography specific report
  • Request historical analysis
  • Check out special discounted pricing

Why Choose Us

  • Research support24/5 Research support

    Get queries resolved by industry expert.

  • Custom research serviceCustom research service

    Exclusive reports and studies to meet your custom requirements.

  • Quality assuranceQuality assurance

    Widely acclaimed services reccomended by major organizations.

  • Information securityInformation security

    Your personal information security guaranteed.

  • sheer analytics and insights PCI DSS complaintsheer analytics and insights paypal verified
Registered Office
RDB Boulevard, 8th Floor, Plot K 1, Sector 5, Block EP and GP, Kolkata 700091, India.
Contact Us
Stay Informed
Submit Your Query
Hot Links